NSE: CLEAN | BSE: 543318

Expensive Underperformer

Download real time

760.50 -7.30 (-0.95%)

49.20% Fall from 52W High

182.0K NSE+BSE Volume

NSE 30 Jun, 2026 3:31 PM (IST)

8,082.8

Market Cap

High in industry

Beta 1Year

High Volatility

Clean Science & Technology Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for CLEAN, BSE:543318 Clean Science & Technology Ltd.

Search Inside the pdf :

Clean Science & Technology Ltd.

15 May 2026

760.50

-0.95%

Clean Science and Technology: Q4FY26 Result Review

Hold: Clean Science & Technology...

IDBI Capital

Clean Science and Technology (Clean) reported results which were above our expectations. Standalone revenue declined by 20% YoY which was majorly owing to lower offtake of established products, pricing pressure and loss of a Chinese customer for the 4-MAP product. Sharp decline in end product pricing amid high Chinese competitive intensity have impacted realisations in FY26. Market conditions have remained very challenging amid muted demand, pricing and tariff pressures. HALS exhibited healthy performance in FY26 with revenue growth of 83% YoY which mitigated the weakness in the standalone...

Clean Science has lost -48.07% in the last 1 Year

Clean Science & Technology Ltd.

01 Feb 2026

760.50

-0.95%

Clean Science and Technology: Q3FY26 Result Review

Hold: Clean Science & Technology...

Recommendation Target

IDBI Capital

Clean Science and Technology (Clean) reported results which were much below our expectations. Volumes declined by 19% YoY leading to a 20% decline in standalone revenues. The decline in revenues was on account of drop in sales volumes of established products. This was owing to sharp decline in end product pricing amid high Chinese competitive intensity. Market conditions remained very challenging amid muted demand, pricing and tariff pressures. Chinese led competition has led to sharp downward pressure on Hydroquione (HQ) and Monomethyl Ether of Hydroquinone (MEHQ) prices impacting profitability. We...

Clean Science has lost -48.07% in the last 1 Year

Clean Science & Technology Ltd.

07 Nov 2025

760.50

-0.95%

Established products facing demand headwinds in near-term

Hold: Clean Science & Technology...

Recommendation Target

ICICI Securities Limited

Clean Science’s (CST) performance was impacted from a dip in volumes owing to demand headwinds and a Chinese customer backward integrating.

Number of FII/FPI investors decreased from 148 to 137 in Mar 2026 qtr

Clean Science & Technology Ltd.

07 Nov 2025

760.50

-0.95%

Clean Science and Technology: Q2FY26 Result Review

Buy: Clean Science & Technology...

Target

IDBI Capital

Clean Science and Technology (Clean) reported results which were below our expectations. Volumes declined by almost 6% YoY leading to a ~7% decline in standalone revenues. The decline in revenues was owing to drop in sales volumes of established products. This was owing to sharp decline in end product pricing amid high Chinese competitive intensity. End markets of these products for certain customers are also seeing lower demand visibility. The management mentioned that one of the prominent FMCG Chinese customer could also have backward integrated which would mean permanent loss of volumes. However,...

Clean Science & Technology Ltd. is trading below all available SMAs

Clean Science & Technology Ltd.

06 Nov 2025

760.50

-0.95%

Clean Science and Technology (CLEAN IN) Q2FY26 Result Update...

Hold: Clean Science & Technology...

Target

Prabhudas Lilladhar

Number of FII/FPI investors decreased from 148 to 137 in Mar 2026 qtr

Clean Science & Technology Ltd.

18 Jul 2025

760.50

-0.95%

Clean Science and Technology (CLEAN IN) Q1FY26 Result Update...

Hold: Clean Science & Technology...

Target

Prabhudas Lilladhar

HALS volume reached 580tn in Q1FY26, sales volume guidance of 4,500tn for FY26 intact, current utilization at 22% Clean Science and Technology (CLEAN) reported revenue of Rs2.4bn in Q1FY26, marking an 8.4% YoY increase but a 7.9% QoQ decline. The sequential dip in topline was due to lower sales of newer products such as DCC and TBHQ. The Pharma & Agro Intermediates segment witnessed the sharpest decline, with revenue down 32% QoQ. Volume for the company's established products...

Promoters initiated pledges of 0.64% of holdings in Mar 2026 qtr.

Clean Science & Technology Ltd.

18 Jul 2025

760.50

-0.95%

Demand slowdown impacting growth; margins holding up well

Sell: Clean Science & Technology...

Recommendation Target

ICICI Securities Limited

Clean Science’s (CST) EBITDA grew only 5.5% YoY despite tailwinds of lower input prices, and HALS offtake. Its established products revenue has grown 8% YoY, while lower sales were due to weak demand for new products.

Promoters initiated pledges of 0.64% of holdings in Mar 2026 qtr.

Clean Science & Technology Ltd.

18 Jul 2025

760.50

-0.95%

Clean Science and Technology: Q1FY26 Result Review

Buy: Clean Science & Technology...

Target

IDBI Capital

Clean Science and Technology (Clean) reported results which were in line with our expectations. The management stated that the growth is majorly led by volumes as realisations are steady. Favourable product mix led to better margin delivery at 41% as established products like MEHQ/BHA saw better growth while products with lesser salience like DCC, TBHQ and others saw weaker growth. Sales volume for HALS stood at 580 tons with total sales of Rs 240 mn in Q1FY26.The management maintained the target of 4500 tons and sales of Rs 2.1 bn for HALS in FY26 which will be driven through introduction of more...

Promoters initiated pledges of 0.64% of holdings in Mar 2026 qtr.

Clean Science & Technology Ltd.

23 May 2025

760.50

-0.95%

Clean Science and Technology: Q4FY25 Result Review

Buy: Clean Science & Technology...

Recommendation Target

IDBI Capital

Number of FII/FPI investors decreased from 148 to 137 in Mar 2026 qtr

Clean Science & Technology Ltd.

22 May 2025

760.50

-0.95%

Clean Science and Technology (CLEAN IN) Q4FY25 Result Update...

Hold: Clean Science & Technology...

Target

Prabhudas Lilladhar

reflecting a 15.9% YoY increase and a 9.5% QoQ growth. The top-line expansion of HALS rose significantly to 1,900tn in FY25 from 600tn in FY24, with a blended realization of Rs425/kg. Management has guided for HALS volumes to reach 4,500tn in FY26, with realizations expected to improve to Rs495...

Promoters initiated pledges of 0.64% of holdings in Mar 2026 qtr.

VOTE: Is Clean Science & Technology Ltd. worth buying?

249 Votes:

Buy 77.91%

Sell 11.65%

Hold 10.44%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf